Cancer risk in patients with type 2 diabetes mellitus and their relatives

International Journal of Cancer

Volumn 137, Issue 4, 2015, Pages 903-910

  Liu, Xiangdong ^a   Hemminki, Kari ^a,b   Försti, Asta ^a,b   Sundquist, Kristina ^a,c   Sundquist, Jan ^a,c   Ji, Jianguang ^a  

^a LUND UNIVERSITY HOSPITAL   (Sweden)

^b GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^c STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

cancer; risk; type 2 diabetes mellitus

Indexed keywords

ADULT; AGED; ARTICLE; CANCER LOCALIZATION; CANCER RISK; COLON CANCER; DISEASE ASSOCIATION; ENDOMETRIUM CANCER; FEMALE; FOLLOW UP; HUMAN; KIDNEY CANCER; LIVER CANCER; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PANCREAS CANCER; PRIORITY JOURNAL; PROSTATE CANCER; RELATIVE; RISK ASSESSMENT; STANDARDIZED INCIDENCE RATIO; AGED, 80 AND OVER; COMPLICATION; DIABETES MELLITUS, TYPE 2; HUMANS; MIDDLE AGED; NEOPLASMS; PATHOLOGY; REGISTRIES; RISK FACTORS;

AGED; AGED, 80 AND OVER; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASMS; REGISTRIES; RISK FACTORS;

EID: 84931561019     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.29440     Document Type: Article

References (32)

1. The National Diabetes Statistics Report. American Diabetes Association, 2014.
2. Hemminki K, Li X, Sundquist K, Sundquist J,. Familial risks for type 2 diabetes in sweden. Diabetes Care 2010; 33: 293-7.
3. Doria A, Patti ME, Kahn CR,. The emerging genetic architecture of type 2 diabetes. Cell Metab 2008; 8: 186-200.
4. Hemminki K, Li X, Sundquist J, et al., Risk of cancer following hospitalization for type 2 diabetes. Oncologist 2010; 15: 548-55.
5. Giovannucci E, Michaud D,. The role of obesity and related metabolic disturbances in cancers of the colon, prostate, and pancreas. Gastroenterology 2007; 132: 2208-25.
6. Hjartaker A, Langseth H, Weiderpass E,. Obesity and diabetes epidemics: cancer repercussions. Adv Exp Med Biol 2008; 630: 72-93.
7. Vigneri P, Frasca F, Sciacca L, et al., Diabetes and cancer. Endocr Relat Cancer 2009; 16: 1103-23.
8. Xue F, Michels KB,. Diabetes, metabolic syndrome, and breast cancer: a review of the current evidence. Am J Clin Nutr 2007; 86: s823-35.
9. Annual Report 2012. Swedish National Diabetes Register, 2012.
10. Gudbjornsdottir S, Cederholm J, Nilsson PM, et al., Steering committee of the swedish national diabetes, register. The national diabetes register in sweden: an implementation of the st. Vincent declaration for quality improvement in diabetes care. Diabetes Care 2003; 26: 1270-6.
11. Atchison EA, Gridley G, Carreon JD, et al., Risk of cancer in a large cohort of U.S. veterans with diabetes. Int J Cancer 2011; 128: 635-43.
12. Turner EL, Lane JA, Donovan JL, et al., Association of diabetes mellitus with prostate cancer: nested case-control study (prostate testing for cancer and treatment study). Int J Cancer 2011; 128: 440-6.
13. Lambe M, Wigertz A, Garmo H, et al., Impaired glucose metabolism and diabetes and the risk of breast, endometrial, and ovarian cancer. Cancer Causes Control 2011; 22: 1163-71.
14. Stenstrom G, Gottsater A, Bakhtadze E, et al., Latent autoimmune diabetes in adults: definition, prevalence, beta-cell function, and treatment. Diabetes 2005; 54: S68-72.
15. Giovannucci E, Harlan DM, Archer MC, et al., Diabetes and cancer: a consensus report. Diabetes Care 2010; 33: 1674-85.
16. Pollak M,. Insulin and insulin-like growth factor signalling in neoplasia. Nat Rev Cancer 2008; 8: 915-28.
17. Masur K, Vetter C, Hinz A, et al., Diabetogenic glucose and insulin concentrations modulate transcriptome and protein levels involved in tumor cell migration, adhension and proliferation. Br J Cancer 2011; 104: 345-52.
18. Emerging Risk Factors Collaboration., Seshasai SR, Kaptoge S, Thompson A, et al., Diabetes mellitus, fasting glucose, and risk of cause-specific death. N Engl J Med 2011; 364: 829-41.
19. Strickler HD, Wylie-Rosett J, Rohan T, et al., The relation of type 2 diabetes and cancer. Diabetes Technol Ther 2001; 3: 263-74.
20. Bao B, Wang Z, Li Y, Kong D, Ali S, Banerjee S, Ahmad A, Sarkar FH,. The complexities of obesity and diabetes with the development and progression of pancreatic cancer. Biochimica Et Biophysica Acta 2011; 1815: 135-46.
21. Kornmann M, Maruyama H, Bergmann U, et al., Enhanced expression of the insulin receptor substrate-2 docking protein in human pancreatic cancer. Cancer Res 1998; 58: 4250-4.
22. Inoue M, Tsugane S,. Insulin resistance and cancer: epidemiological evidence. Endocr Relat Cancer 2012; 19: F1-8.
23. Chen J, Yuan T, Liu M, et al., Association between TCF7L2 gene polymorphism and cancer risk: a meta-analysis. PLoS One 2013; 8: 1793-800.
24. Fall K, Garmo H, Gudbjornsdottir S, et al., Diabetes mellitus and prostate cancer risk; a nationwide case-control study within PCBaSe sweden. Cancer Epidemiol Biomarkers Prev 2013; 22: 1102-9.
25. Wigle DT, Turner MC, Gomes J, et al., Role of hormonal and other factors in human prostate cancer. J Toxicol Environ Health B Crit Rev 2008; 11: 242-59.
26. Pierce BL,. Why are diabetics at reduced risk for prostate cancer? a review of the epidemiologic evidence. Urol Oncol 2012; 30: 735-43.
27. Onitilo AA, Engel JM, Glurich I, et al., Diabetes and cancer II: role of diabetes medications and influence of shared risk factors. Cancer Causes Control 2012; 23: 991-1008.
28. Preston MA, Riis AH, Ehrenstein V, et al., Metformin use and prostate cancer risk. Eur Urol 2014; 66: 1012-20.
29. Jianguang J, Kristina S, Jan S, et al., Comparability of cancer identification among death registry, cancer registry and hospital discharge registry. Int J Cancer 2012; 131: 2085-93.
30. Smith U, Gale EA,. Does diabetes therapy influence the risk of cancer? Diabetologia 2009; 52: 1699-708.
31. Miao Jonasson J, Cederholm J, Eliasson B, et al., HbA1C and cancer risk in patients with type 2 diabetes-a nationwide population-based prospective cohort study in sweden. PLoS One 2012; 7: e38784
32. Miao Jonasson J, Cederholm J, Gudbjornsdottir S,. Excess body weight and cancer risk in patients with type 2 diabetes who were registered in swedish national diabetes register-register-based cohort study in sweden. PLoS One 2014; 9: e105868